Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Apple
AAPL
|
+$704M |
| 3 |
Amazon
AMZN
|
+$670M |
| 4 |
Merck
MRK
|
+$431M |
| 5 |
NVIDIA
NVDA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$441M |
| 2 |
JD.com
JD
|
+$196M |
| 3 |
Aon
AON
|
+$184M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$165M |
| 5 |
Dell
DELL
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.01% |
| 4 | Consumer Discretionary | 11.99% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Caribou Biosciences
CRBU
$160M
| $5.46M | ﹤0.01% |
361,632
+19,417
| +6% | +$378K |
|
2852
Viking Therapeutics
VKTX
$3.91B
| $5.43M | ﹤0.01% |
1,181,655
-5,667
| -0.5% | -$31.8K |
|
2853
Primis Financial Corp
FRST
$409M
| $5.43M | ﹤0.01% |
360,803
-3,813
| -1% | -$57.9K |
|
|
ONIT
2854
Onity Group
ONIT
$321M
| $5.4M | ﹤0.01% |
135,124
+13,641
| +11% | +$460K |
|
2855
Adicet Bio
ACET
$85.6M
| $5.4M | ﹤0.01% |
19,283
-1,927
| -9% | -$331K |
|
2856
Pliant Therapeutics
PLRX
$65M
| $5.39M | ﹤0.01% |
399,694
+79,240
| +25% | +$1.26M |
|
2857
Standard BioTools
LAB
$307M
| $5.39M | ﹤0.01% |
1,375,762
+26,003
| +2% | +$122K |
|
2858
Quantum Corp
QMCO
$456M
| $5.39M | ﹤0.01% |
48,835
-1,634
| -3% | -$186K |
|
|
ZY
2859
DELISTED
Zymergen Inc. Common Stock
ZY
| $5.39M | ﹤0.01% |
805,245
+502,228
| +166% | +$4.88M |
|
2860
ESS Tech
GWH
$21.4M
| $5.37M | ﹤0.01% |
31,316
+29,537
| +1,660% | +$6.52M |
|
|
PRVB
2861
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $5.37M | ﹤0.01% |
955,334
-84,772
| -8% | -$538K |
|
|
BDSI
2862
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $5.34M | ﹤0.01% |
1,724,411
-24,223
| -1% | -$81.5K |
|
|
CURO
2863
DELISTED
CURO Group Holdings Corp.
CURO
| $5.33M | ﹤0.01% |
332,849
+27,997
| +9% | +$487K |
|
|
ESTE
2864
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $5.32M | ﹤0.01% |
486,423
+50,659
| +12% | +$540K |
|
2865
Plains All American Pipeline
PAA
$16.3B
| $5.32M | ﹤0.01% |
569,218
+3,385
| +0.6% | +$34K |
|
|
GBIO
2866
DELISTED
Generation Bio
GBIO
| $5.3M | ﹤0.01% |
74,922
-3,742
| -5% | -$653K |
|
2867
Scorpio Tankers
STNG
$3.71B
| $5.3M | ﹤0.01% |
413,539
-8,334
| -2% | -$129K |
|
2868
EverQuote
EVER
$834M
| $5.28M | ﹤0.01% |
337,444
+120,411
| +55% | +$1.84M |
|
2869
Covenant Logistics
CVLG
$900M
| $5.27M | ﹤0.01% |
399,038
-2,368
| -0.6% | -$32.5K |
|
2870
Tiptree Inc
TIPT
$667M
| $5.26M | ﹤0.01% |
380,396
+40,401
| +12% | +$566K |
|
2871
NWPX Infrastructure Inc
NWPX
$1.2B
| $5.24M | ﹤0.01% |
164,773
-797
| -0.5% | -$21.9K |
|
2872
Eos Energy Enterprises
EOSE
$1.38B
| $5.24M | ﹤0.01% |
696,216
-738
| -0.1% | -$7.5K |
|
2873
Costamare
CMRE
$1.77B
| $5.23M | ﹤0.01% |
413,169
+1,276
| +0.3% | +$16.7K |
|
|
ICVX
2874
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $5.23M | ﹤0.01% |
228,447
+10,758
| +5% | +$278K |
|
2875
Pure Cycle
PCYO
$255M
| $5.21M | ﹤0.01% |
356,537
-33,483
| -9% | -$502K |
|
Similar funds
Geode Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Geode Capital Management held 5,071 positions worth $830B, up 12% from $743B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q4 2021 filing shows 216 new, 2,976 increased, 1,070 reduced and 95 closed positions. Its largest new stake was Rivian: 2,078,098 shares worth $215M. The largest sale was Kansas City Southern, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2021 buy was Rivian: 2,078,098 shares worth $215M.
- Geode Capital Management added most to Microsoft in Q4 2021, an estimated $981M increase.
- Geode Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $196M.
- Geode Capital Management fully exited Kansas City Southern in Q4 2021, selling an estimated $441M.
- Geode Capital Management's ten largest holdings make up 24% of its $830B portfolio in Q4 2021.
- Geode Capital Management opened 216 new positions and closed 95 in Q4 2021.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $830B.
Based on Geode Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.